UBE2S and hepatocellular carcinoma: Through in vitro research, overexpression of UBE2S in HCC cells caused a rise in resistance to 5‐fluorouracil (5‐FU) and oxaliplatin, while when UBE2S was suppressed, a reverse impact was observed [38].